B-CELL LYMPHOMA REFRACTORY

Clinical trials for B-CELL LYMPHOMA REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear

Sign up with your email to follow new studies for B-CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

Singapore hospital tests 'Living Drug' to fight aggressive lymphoma

Disease control Not yet recruiting

This trial is testing a personalized cell therapy for patients whose B-cell lymphoma has returned or not responded to other treatments. Doctors will modify a patient's own immune cells to better target and fight their cancer. The study will first find a safe dose and then see how…

Matched conditions: B-CELL LYMPHOMA REFRACTORY

Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

B-CELL LYMPHOMA REFRACTORY

Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear

Singapore hospital tests 'Living Drug' to fight aggressive lymphoma